Travere Therapeutics, Inc.
TVTX· Nasdaq
TVTXTravere Therapeutics, Inc.
Source filing unavailable
| Metric | Q4 2013 | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | — |
| Net Income | -$12.82M | -$13.53M | -$4.26K | — |
| EPS Diluted | -$0.70 | — | — |
Travere Therapeutics, Inc. · CIK 1438533 · Engraved from SEC EDGAR
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
